{"id":40262,"date":"2026-01-31T13:29:00","date_gmt":"2026-01-31T12:29:00","guid":{"rendered":"https:\/\/usamedical.com\/en\/?post_type=product&p=40262"},"modified":"2026-08-27T19:27:08","modified_gmt":"2026-08-28T02:27:08","slug":"mio-inositol-and-d-chiro-inositol-caromax-capsules-60-pcs","status":"publish","type":"product","link":"https:\/\/usamedical.com\/en\/product\/mio-inositol-and-d-chiro-inositol-caromax-capsules-60-pcs\/","title":{"rendered":"Myo + D-Chiro Inositol"},"content":{"rendered":"
\n

Hormone + Metabolic Balance, Made Simple<\/h2>\n

Two capsules provide 1,000 mg myo-inositol plus 25 mg D-chiro-inositol. The purpose is clear at a glance: a transparent 40:1 inositol routine for everyday hormone and metabolic support.<\/p>\n

\n
40:1<\/strong>Myo-inositol to D-chiro-inositol<\/span><\/div>\n
\n
1,000 mg<\/strong>Myo-inositol per serving.<\/span><\/div>\n
25 mg<\/strong>D-chiro-inositol per serving.<\/span><\/div>\n
1,025 mg total<\/strong>Combined inositols per serving.<\/span><\/div>\n
30 servings<\/strong>Two capsules once daily.<\/span><\/div>\n<\/div>\n<\/div>\n

What This Formula Is Built For<\/h3>\n
\n
\n

Hormone support<\/h3>\n

Inositol is studied in hormone-related contexts, particularly in women with PCOS. This product supports a daily hormone-balance routine; it is not a treatment for PCOS or infertility.[1]<\/a>[2]<\/a><\/p>\n<\/div>\n

\n

Metabolic support<\/h3>\n

Reviews report possible improvements in some metabolic measures, but the overall evidence remains limited and outcomes are not consistent across studies.[1]<\/a><\/p>\n<\/div>\n

\n

Transparent 40:1 ratio<\/h3>\n

The serving gives 40 parts myo-inositol for every 1 part D-chiro-inositol. The ratio describes composition; by itself it does not prove a clinical outcome.[3]<\/a><\/p>\n<\/div>\n

\n

Exact daily amount<\/h3>\n

This formula provides 1,025 mg total inositols per day. Several cited protocols use larger daily totals, so their results are not dose-equivalent to this product.[3]<\/a>[4]<\/a><\/p>\n<\/div>\n

\n

One daily serving<\/h3>\n

Two capsules make one complete serving, with 30 servings in a 60-capsule bottle.<\/p>\n<\/div>\n

\n

Evidence-aware boundaries<\/h3>\n

The 2023 international guideline does not recommend a specific inositol type, ratio, or dose because the quality and consistency of evidence remain limited.[2]<\/a><\/p>\n<\/div>\n<\/div>\n

\nWhat the research says<\/span><\/p>\n

Promising in some measures. Not a proven PCOS treatment.<\/h3>\n

A systematic review of 30 trials found possible benefits for some metabolic measures, while many clinical outcomes were uncertain or showed no clear effect. The authors concluded that evidence remains limited and inconclusive.[1]<\/a><\/p>\n

The 2023 international guideline says inositol may be considered according to personal preferences because harm appears limited and some metabolic measures may improve, but clinical benefits are limited and no specific type or dose can be recommended.[2]<\/a><\/p>\n

Our honest read: the formula is appealing because its two forms, ratio, and serving amount are transparent. It should not be sold as a guaranteed hormone, fertility, ovulation, weight, cholesterol, or glucose outcome.<\/p>\n<\/div>\n

What 40:1 Does, and Does Not, Mean<\/h3>\n
\n
Number<\/span>What it means here<\/span>What it does not mean<\/span><\/div>\n
1,000 mg<\/strong>Myo-inositol in one daily serving.<\/span>Not automatically equivalent to a multi-gram study protocol.<\/span><\/div>\n
25 mg<\/strong>D-chiro-inositol in one daily serving.<\/span>Not proof that a different daily amount has the same effect.<\/span><\/div>\n
40:1<\/strong>The relationship between the two listed amounts.<\/span>Not a clinical guarantee or guideline-endorsed universal ratio.<\/span><\/div>\n<\/div>\n
\"Myo<\/a>
Hormone + metabolic balance, made simple.<\/figcaption><\/figure>\n
\n
\n

Works Cited<\/h2>\n<\/header>\n
\n
\n
Systematic review<\/span>01<\/span><\/div>\n

Inositol for PCOS<\/h3>\n

The review behind the 2023 guideline evaluated 30 trials and found potential in some metabolic measures but limited and inconclusive evidence overall.<\/p>\n

Read the systematic review \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
International guideline<\/span>02<\/span><\/div>\n

2023 PCOS Guideline<\/h3>\n

The guideline says inositol may be considered according to individual preferences, while emphasizing limited clinical benefits and insufficient evidence to recommend a specific type or dose.<\/p>\n

Read the guideline \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
Small clinical study<\/span>03<\/span><\/div>\n

Comparing Myo:D-Chiro Ratios<\/h3>\n

A small trial compared several ratios at a substantially higher total daily amount. The 40:1 group included only eight participants.<\/p>\n

Read the PubMed record \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
Open prospective study<\/span>04<\/span><\/div>\n

A 40:1 Combination<\/h3>\n

This uncontrolled study followed 34 women using a 40:1 combination at 2,255 mg daily, more than the 1,025 mg in this product.<\/p>\n

Read the PubMed record \u2197<\/span><\/a><\/div>\n<\/article>\n<\/div>\n